Listed

Trimas Corp: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Oct 27, 2022 and accepted by EDGAR at Oct 27, 2022, 11:42 ET.

Share

Management's discussion and analysis

As filed, 70,909 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition contains forward-looking statements regarding industry outlook and our expectations regarding the performance of our business. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described under the heading "Forward-Looking Statements," at the beginning of this report. Our actual results may differ materially from those contained in or implied by any forward-looking statements. You should read the following discussion together with the Company's reports on file with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2021.

Introduction

TriMas designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Our wide range of innovative products are designed and engineered to solve application-specific challenges that our customers face. We believe our businesses share important and distinguishing characteristics, including: well-recognized and leading brand names in the focused markets we serve; innovative product technologies and features; a high-degree of customer approved processes and qualifications; established distribution networks; relatively low ongoing capital investment requirements; strong cash flow conversion and long-term growth opportunities. While the majority of our revenue is in the United States, we manufacture and supply products globally to a wide range of companies. We report our business activity in three segments: Packaging, Aerospace and Specialty Products.

Key Factors Affecting Our Reported Results

Our businesses and results of operations depend upon general economic conditions. We serve customers in industries that are highly competitive, cyclical and that may be significantly impacted by changes in economic or geopolitical conditions.

Over the past two years, the coronavirus ("COVID-19") pandemic has significantly affected each of our businesses and how we operate, albeit in different ways and magnitudes. Sales in our Packaging segment for dispensing and closure products used in applications to help fight the spread of germs have experienced extreme volatility in demand, with demand spiking to record highs after the onset of the pandemic, demand abating as expected from those high levels over the past year, and in third quarter 2022, which normally is strong ordering period heading into a holiday selling season, demand abruptly fell as a result of some of our large consumer goods customers' choices to rebalance on-hand inventory levels given the current macro-economic environment. Sales of certain of our industrial and aerospace-related products were significantly depressed from historical levels during 2020 and 2021. Our aerospace-related product sales continue to be lower than historical levels, although demand continues to increase, while certain industrial product sales have recovered to pre-pandemic levels. The pandemic has also led to increased uncertainty and higher inflation rates in the global business environment, and we have experienced increases in input costs (raw materials, wage rates, energy and freight), supply chain disruptions and delays, as well as labor availability challenges, all pressuring our ability to operate efficiently and at the margin levels previously experienced.

We have been, and continue to be, focused on ensuring the working environments for our employees are safe. At the onset of the pandemic, we implemented new work rules and processes, which promote social distancing and increased hygiene to ensure the safety of our employees, particularly at our production facilities. These measures, plus other governmental regulation and sick-time rules, have increased the level of manufacturing inefficiencies including elevated levels of absenteeism, less efficient production scheduling and, in certain cases, short-term idling of production. While these increased costs and inefficiencies began in 2020, they continue to persist. In fact, with increased demand volatility and inflationary pressures, some of the inefficiencies have exacerbated in 2022, most notably in our Aerospace segment, and we believe all such items aggregated to more than $2 million in third quarter year-over-year cost pressure. Given these factors, we believe that labor-related availability and inefficiencies will be an ongoing challenge.

Overall, our third quarter 2022 net sales decreased $3.9 million, or (1.7)%, compared to third quarter 2021. Sales increased within our Specialty Products segment as a result of increased industrial demand and higher oil-field activity in North America. Sales also increased as a result of recent acquisitions in our Packaging and Aerospace segments, as well as from sales of products used in food and beverage markets within our Packaging segment. These factors were more than offset primarily by an abrupt reduction in demand for personal care and home care products in our Packaging segment, as well as unfavorable currency exchange.

The most significant drivers affecting our financial results in third quarter 2022 compared with third quarter 2021, other than as directly impacted by sales changes or as a result of the labor-related availability and and inefficiencies, were the impact of our recent acquisitions, the impact of higher energy and other input costs, the gain on the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility within our Aerospace segment, and the settlement of our cross currency swaps.

In February 2022, we acquired Intertech Plastics LLC and related companies (collectively, "Intertech"), a manufacturer of custom injection molded products used in medical applications, as well as products and assemblies for consumer and industrial applications, for an aggregate amount of $64.1 million, net of cash acquired. Intertech, which is reported in the Company's Packaging segment, has two manufacturing facilities located in the Denver, Colorado area. Intertech contributed $8.8 million of net sales during third quarter 2022.

In December 2021, we completed the acquisition of Omega Plastics ("Omega"), which specializes in manufacturing custom components and devices for drug delivery, diagnostic and orthopedic medical applications, as well as components for industrial applications, for an aggregate amount of $22.5 million, net of cash acquired. Omega, which is reported in the Company's Packaging segment, is located in Clinton Township, Michigan. Omega contributed $2.7 million of net sales during third quarter 2022.

In December 2021, we acquired TFI Aerospace ("TFI"), a manufacturer and supplier of specialty fasteners used in a variety of applications, predominately for the aerospace end market, for an aggregate amount of $11.8 million, with additional contingent consideration ranging from zero to $12.0 million to be paid based on 2023 and 2024 earnings per the purchase agreement. TFI, which is reported in the Company's Aerospace segment, is located near Toronto, Canada. TFI contributed $1.3 million of net sales during third quarter 2022.

We also experienced a significant increase in the cost of energy, primarily in our Europe-based operations, as well as for other input costs in third quarter 2022 compared with third quarter 2021. Energy costs began to rise during late 2021, and have further increased into 2022, which we believe is primarily due to geopolitical tensions associated with the Russia-Ukraine conflict, as well as realized and expected energy supply constraints. Energy costs were more than $2 million and $5 million higher in the three and nine months ended September 30, 2022 than the three and nine months ended September 30, 2021, respectively. We expect there could be additional cost and supply chain pressures going forward as a result of the uncertainty surrounding the conflict in Eastern Europe.

In third quarter 2022, we completed the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility and recognized a pre-tax gain of $4.8 million within our Aerospace segment. We received pre-tax net cash proceeds of $5.0 million in October 2022.

In third quarter 2022, we terminated our existing cross-currency swap agreements, de-designating the swaps as net investment hedges and received $26.2 million of cash. The cross-currency swap agreements had notional amounts totaling $250.0 million, which declined to $25.0 million over various contract periods ending between October 15, 2023 and October 15, 2027.

On a year-to-date basis, there were three additional significant drivers of change in our year-over-year results of operations.

Beginning in second quarter 2020, we have been executing certain realignment actions in response to current and expected future end market demand following the onset of the COVID-19 pandemic, as well as for the move to our new Packaging facility in New Albany, Ohio. We recorded pre-tax facility move/consolidation and employee-related costs of $2.5 million and $1.8 million, respectively, in the nine months ended September 30, 2022. In the nine months ended September 30, 2021, we recorded pre-tax facility consolidation and employee separation costs of $2.7 million and $6.1 million, respectively.

In March 2021, we refinanced our long-term debt, issuing $400 million principal amount of 4.125% senior unsecured notes due April 15, 2029 ("2029 Senior Notes") at par value in a private placement offering, and amending our existing credit agreement ("Credit Agreement"), extending the maturity to March 2026. We used the proceeds from the 2029 Senior Notes offering to pay fees and expenses of $5.1 million related to the offering and $1.1 million related to amending the Credit Agreement. The remaining cash proceeds from the 2029 Senior Notes were used for general corporate purposes, including repaying all outstanding revolving credit facility borrowings. In April 2021, we completed the refinancing, redeeming all of our outstanding senior notes due October 2025 ("2025 Senior Notes"), paying cash for the entire $300.0 million outstanding principal amount plus $7.3 million as a redemption premium. The $5.1 million of fees and expenses related to the 2029 Senior Notes were capitalized as debt issuance costs, while the $7.3 million redemption premium as well as $3.0 million of unamortized debt issuance costs associated with the 2025 Senior Notes were expensed in the second quarter of 2021.

Our effective tax rate for the nine months ended September 30, 2022 and 2021 was 25.0% and 19.2%, respectively. The rate for the nine months ended September 30, 2022 is higher primarily as a result of the recognition of $3.0 million of deferred tax benefits in Italy during the nine months ended September 30, 2021, the majority of which related to a reduction in deferred tax liabilities in connection with certain tax incentives.

Additional Key Risks that May Affect Our Reported Results

We have executed significant realignment actions since the onset of the COVID-19 pandemic, primarily in our Aerospace and Specialty Products segments, and also in certain Packaging product areas where demand has fallen. We will continue to assess further actions if required. However, as a result of the current period of macroeconomic inflation and uncertainty, the continued impact of the COVID-19 pandemic, and the potential impact of such factors to our future results of operations, as well if there is an impact to TriMas' market capitalization, we may record additional cash and non-cash charges related to incremental realignment actions, asset impairments as well as for uncollectible customer account balances, excess inventory and idle production equipment.

Despite the potential for declines in future demand levels and results of operations, at present, we believe our capital structure is in a strong position. We have sufficient cash and available liquidity under our revolving credit facility to meet our debt service obligations, capital expenditure requirements and other short-term and long-term obligations for the foreseeable future.

The extent of the COVID-19 pandemic's effect on our operational and financial performance will depend in large part on future developments, which cannot be predicted with confidence at this time. Future developments include the duration, scope and severity of the COVID-19 pandemic, the actions taken to contain or mitigate its impact, timing and acceptance of widespread vaccine availability, and the resumption of normalized global economic activity. Due to the inherent uncertainty of the unprecedented and rapidly evolving situation, we are unable to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations.

Beyond the unique risks presented by the COVID-19 pandemic, other critical factors affecting our ability to succeed include: our ability to create organic growth through product development, cross-selling and extending product-line offerings, and our ability to quickly and cost-effectively introduce and successfully launch new products; our ability to acquire and integrate companies or products that supplement existing product lines, add new distribution channels or customers, expand our geographic coverage or enable better absorption of overhead costs; our ability to manage our cost structure more efficiently via supply chain management, internal sourcing and/or purchasing of materials, selective outsourcing and/or purchasing of support functions, working capital management, and greater leverage of our administrative functions; and our ability to absorb, or recover via commercial actions, inflationary or other cost increases.

Our overall business does not experience significant seasonal fluctuation, other than our fourth quarter, which has tended to be the lowest net sales quarter of the year due to holiday shutdowns at certain customers or other customers deferring capital spending to the following year. Given the short-cycle nature of most of our businesses, we do not consider sales order backlog to be a material factor. A growing amount of our sales is derived from international sources, which exposes us to certain risks, including currency risks.

We are sensitive to price movements and availability of our raw materials supply. Our largest raw material purchases are for resins (such as polypropylene and polyethylene), steel, aluminum and other oil and metal-based purchased components. In addition to the factors affecting our 2021 and 2022 results, there has been some volatility over the past two years as a direct and indirect result of foreign trade policy, where tariffs on certain of our commodity-based products sourced from Asia have been instituted, and certain North American suppliers have opportunistically increased their prices. We will continue to take actions to mitigate such increases, including implementing commercial pricing adjustments, resourcing to alternate suppliers and insourcing of previously sourced products to better leverage our global manufacturing footprint. Although we believe we are generally able to mitigate the impact of higher commodity costs over time, we may experience additional material costs and disruptions in supply in the future and may not be able to pass along higher costs to our customers in the form of price increases or otherwise mitigate the impacts to our operating results.

Although we have escalator/de-escalator clauses in commercial contracts with certain of our customers, or can modify prices based on market conditions to recover higher costs, our price increases generally lag the underlying material cost increase, and we cannot be assured of full cost recovery in the open market. If input costs increase at rapid rates, as they did during 2021, our ability to recover cost increases on a timely basis is made more difficult by the lag nature of these contracts.

Our Arrow Engine business in our Specialty Products segment is sensitive to the demand for natural gas and crude oil in North America. For example, demand for engine, pump jack and compressor products are impacted by active oil and gas rig counts and wellhead investment activities. Separately, oil-based commodity costs are a significant driver of raw materials and purchased components used within our Packaging segment.

Each year, as a core tenet of the TriMas Business Model, our businesses target cost savings from Kaizen and continuous improvement initiatives in an effort to reduce, or otherwise offset, the impact of increased input and conversion costs through increased throughput and yield rates, with a goal of at least covering inflationary and market cost increases. In addition, we continuously review our operating cost structures to ensure alignment with current market demand.

We continue to evaluate alternatives to redeploy the cash generated by our businesses, one of which includes returning capital to our shareholders. In 2020, our Board of Directors increased the authorization of share repurchases to a cumulative amount of $250 million. During third quarter 2022, we purchased 76,167 shares of our outstanding common stock for an aggregate purchase price of $2.1 million. As of September 30, 2022, we had $112.7 million remaining under the repurchase authorization.

In addition, in third quarter 2022, we declared dividends of $0.04 per share of common stock and paid dividends of $1.7 million. We will continue to evaluate opportunities to return capital to shareholders through the purchase of our common stock, as well as dividends, depending on market conditions and other factors.

Segment Information and Supplemental Analysis

The following table summarizes financial information for our reportable segments for the three months ended September 30, 2022 and 2021 (dollars in thousands):

Net Sales Three months ended September 30, 2022 As a Percentage of Net Sales 2021 As a Percentage of Net Sales
Packaging $129,700 59.3% $138,010 62.1%
Aerospace 45,420 20.8% 46,510 20.9%
Specialty Products 43,410 19.9% 37,900 17.0%
Total $218,530 100.0% $222,420 100.0%
Gross Profit
Packaging $31,210 24.1% $39,410 28.6%
Aerospace 8,110 17.9% 10,150 21.8%
Specialty Products 9,010 20.8% 8,880 23.4%
Total $48,330 22.1% $58,440 26.3%
Selling, General and Administrative Expenses
Packaging $13,570 10.5% $12,070 8.7%
Aerospace 8,220 18.1% 6,160 13.2%
Specialty Products 2,240 5.2% 2,230 5.9%
Corporate 8,080 N/A 7,160 N/A
Total $32,110 14.7% $27,620 12.4%
Operating Profit (Loss)
Packaging $17,590 13.6% $27,340 19.8%
Aerospace 4,710 10.4% 3,980 8.6%
Specialty Products 6,760 15.6% 6,660 17.6%
Corporate (8,080) N/A (7,160) N/A
Total $20,980 9.6% $30,820 13.9%
Depreciation
Packaging $5,490 4.2% $5,280 3.8%
Aerospace 1,820 4.0% 1,670 3.6%
Specialty Products 850 2.0% 930 2.5%
Corporate 30 N/A 30 N/A
Total $8,190 3.7% $7,910 3.6%
Amortization
Packaging $1,440 1.1% $2,380 1.7%
Aerospace 3,010 6.6% 2,870 6.2%
Specialty Products 110 0.3% 120 0.3%
Corporate — N/A — N/A
Total $4,560 2.1% $5,370 2.4%

28

The following table summarizes financial information for our reportable segments for the nine months ended September 30, 2022 and 2021 (dollars in thousands):

Net Sales Nine months ended September 30, 2022 As a Percentage of Net Sales 2021 As a Percentage of Net Sales
Packaging 416,540 61.2% 409,730 63.2%
Aerospace 137,330 20.2% 135,680 21.0%
Specialty Products 126,650 18.6% 102,730 15.8%
Total $680,520 100.0% $648,140 100.0%
Gross Profit
Packaging 109,350 26.3% 113,770 27.8%
Aerospace 25,760 18.8% 30,430 22.4%
Specialty Products 27,610 21.8% 23,600 23.0%
Total $162,720 23.9% $167,800 25.9%
Selling, General and Administrative Expenses
Packaging 42,400 10.2% 37,090 9.1%
Aerospace 21,270 15.5% 19,840 14.6%
Specialty Products 6,800 5.4% 6,460 6.3%
Corporate 24,010 N/A 26,780 N/A
Total $94,480 13.9% $90,170 13.9%
Operating Profit (Loss)
Packaging 66,720 16.0% 76,490 18.7%
Aerospace 9,300 6.8% 10,600 7.8%
Specialty Products 20,770 16.4% 17,190 16.7%
Corporate (24,010) N/A (26,780) N/A
Total $72,780 10.7% $77,500 12.0%
Depreciation
Packaging 16,690 4.0% 15,680 3.8%
Aerospace 5,730 4.2% 5,260 3.9%
Specialty Products 2,820 2.2% 2,710 2.6%
Corporate 100 N/A 90 N/A
Total $25,340 3.7% $23,740 3.7%
Amortization
Packaging 5,230 1.3% 7,180 1.8%
Aerospace 9,030 6.6% 8,630 6.4%
Specialty Products 340 0.3% 340 0.3%
Corporate — N/A — N/A
Total $14,600 2.1% $16,150 2.5%

Results of Operations

The principal factors impacting us during the three months ended September 30, 2022, compared with the three months ended September 30, 2021, were:

  • the impact on global business activity of the COVID-19 pandemic, as well as volatility and inflationary pressure on input costs, supply chain and labor availability;
  • an abrupt reduction in demand for beauty and personal care and home care products in our Packaging segment;
  • the impact of recent acquisitions, primarily Omega and TFI in December 2021, and Intertech in February 2022;
  • the sale of vacant land in Tolleson, Arizona and the related pre-tax gain recognized in our Aerospace segment.
  • the impact of higher energy costs; and
  • the termination of our existing cross-currency swaps.

Three Months Ended September 30, 2022 Compared with Three Months Ended September 30, 2021

Overall, net sales decreased $3.9 million, or 1.7%, to $218.5 million for the three months ended September 30, 2022, as compared with $222.4 million in the three months ended September 30, 2021. Our Intertech, Omega and TFI acquisitions collectively added $12.8 million of sales for third quarter 2022. Organic sales, excluding the impact of currency exchange and acquisitions, decreased $10.6 million, as increases in our Specialty Products segment as well as for food and beverage in our Packaging segment were partially offset by declines of industrial products and dispensing products that help fight the spread of germs in our Packaging segment and the expected reduction in sales of customers' stocking orders for highly-engineered fasteners in our Aerospace segment. In addition, net sales decreased by $6.1 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of a strengthening U.S. dollar relative to foreign currencies.

Gross profit margin (gross profit as a percentage of sales) approximated 22.1% and 26.3% for the three months ended September 30, 2022 and 2021, respectively. Gross profit margin decreased due to a less favorable sales mix, primarily as a result of lower sales of Aerospace segment customers' stocking orders for highly-engineered fasteners, as well as production inefficiencies resulting from supply chain constraints and volatility in labor availability during the three months ended September 30, 2022. In addition, improved recovery of resin costs in our Packaging segment was more than offset by higher energy costs, primarily in our Packaging segment's European facilities, higher steel costs in our Specialty Products segment, and unfavorable currency exchange.

Operating profit margin (operating profit as a percentage of sales) approximated 9.6% and 13.9% for the three months ended September 30, 2022 and 2021, respectively. Operating profit decreased $9.8 million to $21.0 million in the three months ended September 30, 2022, from $30.8 million for the three months ended September 30, 2021, primarily due to lower sales levels, a less favorable product sales mix, higher energy and steel costs, increased production inefficiencies resulting from supply chain constraints and volatility in labor availability, as well as unfavorable currency exchange, all partially offset by a pre-tax gain of $4.8 million within our Aerospace segment for the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility.

Interest expense increased $0.2 million, to $3.6 million for the three months ended September 30, 2022, compared to $3.4 million for the three months ended September 30, 2021, due to a higher effective interest rate as a result of lower notional amounts of cross-currency swaps.

Other income (expense) increased $1.4 million to $0.9 million of income for the three months ended September 30, 2022, as compared to $0.5 million of expense for the three months ended September 30, 2021, primarily due to an increase in foreign currency transaction gains.

The effective income tax rate for the three months ended September 30, 2022 and 2021 was 27.1% and 27.0%, respectively. We recorded income tax expense of $4.9 million and $7.3 million for the three months ended September 30, 2022 and 2021, respectively.

Net income decreased $6.3 million, to $13.3 million for the three months ended September 30, 2022, as compared to $19.6 million for the three months ended September 30, 2021. The decrease was primarily the result of a decrease in operating profit of $9.8 million and an increase in interest expense of $0.2 million, partially offset by a decrease in income tax expense of $2.3 million and an increase in other income of $1.4 million.

See below for a discussion of operating results by segment.

Packaging. Net sales decreased $8.3 million, or 6.0%, to $129.7 million in the three months ended September 30, 2022, as compared to $138.0 million in the three months ended September 30, 2021. Our recent Intertech and Omega acquisitions collectively contributed $11.5 million of sales during the three months ended September 30, 2022. Sales of products used in food and beverage markets increased by $0.9 million, primarily due to strong demand for closures, dispensers and flexible packaging as the hospitality sector continues to rebound from prior COVID-19 pandemic-related shutdowns. Sales of products used in industrial markets decreased by $2.2 million, primarily as a result of lower demand for drum closure products in North America. Sales of dispensing products used in beauty and personal care, as well as home care, applications that help fight the spread of germs decreased by $13.7 million, primarily due to a reduction in demand from our large consumer goods customers that are choosing to rebalance on-hand inventory levels given the current macro-economic environment. Net sales decreased by $6.1 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening U.S. dollar relative to foreign currencies, as compared to third quarter 2021.

Gross profit decreased $8.2 million to $31.2 million, or 24.1% of sales, in the three months ended September 30, 2022, as compared to $39.4 million, or 28.6% of sales, in the three months ended September 30, 2021. During third quarter 2021, we were impacted by $3 million of higher resin costs than we were able to recover via commercial actions, while in third quarter 2022, we were generally able to recover current resin costs. Gross profit declined in third quarter 2022 due to lower sales levels, $2.2 million of higher energy costs, primarily in our European manufacturing facilities, and $1.6 million of unfavorable currency exchange, as our reported results in U.S. dollars were impacted as a result of the strengthening U.S. dollar relative to foreign currencies. Gross profit margin was also adversely impacted by a less favorable product sales mix.

Selling, general and administrative expenses increased $1.5 million to $13.6 million, or 10.5% of sales, in the three months ended September 30, 2022, as compared to $12.1 million, or 8.7% of sales, in the three months ended September 30, 2021, primarily due to higher ongoing selling, general and administrative costs associated with our acquisitions as we continue to integrate them into our portfolio. Selling, general and administrative expenses would have been approximately flat year-over-year in third quarter without consideration of the Omega and Intertech expenses.

Operating profit decreased $9.8 million to $17.6 million, or 13.6% of sales, in the three months ended September 30, 2022, as compared to $27.3 million, or 19.8% of sales, in the three months ended September 30, 2021, as the impact of improved recovery of material costs was offset by lower sales levels, a less favorable product sales mix, higher energy costs, higher selling, general and administrative expenses and the impact of $0.7 million of unfavorable currency exchange.

Aerospace. Net sales for the three months ended September 30, 2022 decreased $1.1 million, or 2.3%, to $45.4 million, as compared to $46.5 million in the three months ended September 30, 2021. Our December 2021 acquisition of TFI contributed $1.3 million in sales. Sales of our fasteners products decreased by $2.5 million, as increases in demand for fasteners used in new aircraft builds plus market share gains were more than offset by the expected loss of more than $6 million of third quarter 2021 sales of customers' stocking orders for highly-engineered fasteners. Sales of our engineered components products increased by $0.1 million.

Gross profit decreased $2.0 million to $8.1 million, or 17.9% of sales, in the three months ended September 30, 2022, from $10.2 million, or 21.8% of sales, in the three months ended September 30, 2021, primarily due to a less favorable product sales mix in third quarter 2022, with lower sales of the customers' stocking orders for highly-engineered fasteners, as well as production inefficiencies resulting from supply chain constraints and volatility in labor availability.

Selling, general and administrative expenses increased $2.1 million to $8.2 million, or 18.1% of sales, in the three months ended September 30, 2022, as compared to $6.2 million, or 13.2% of sales, in the three months ended September 30, 2021, primarily due to higher ongoing selling, general and administrative costs associated with our acquisition of TFI and due to higher employee-related costs.

Operating profit increased $0.7 million to $4.7 million, or 10.4% of sales, in the three months ended September 30, 2022, as compared to $4.0 million, or 8.6% of sales, in the three months ended September 30, 2021, primarily due to a $4.8 million pre-tax gain on the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility in third quarter 2022, which was largely offset by a less favorable product sales mix, production inefficiencies resulting from supply chain constraints and volatility in labor availability and higher employee-related costs.

Specialty Products. Net sales for the three months ended September 30, 2022 increased $5.5 million, or 14.5%, to $43.4 million, as compared to $37.9 million in the three months ended September 30, 2021. Sales of our cylinder products increased $2.2 million due to higher demand for steel cylinders in North America, as industrial activity continues to increase from depressed levels as a result of the COVID-19 pandemic. Sales of engines, compressors and related parts used in stationary power generation and assistance applications for natural gas and crude oil extraction increased by $3.3 million, primarily as a result of higher oil-field activity in North America.

Gross profit increased $0.1 million to $9.0 million, or 20.8% of sales, in the three months ended September 30, 2022, as compared to $8.9 million, or 23.4% of sales, in the three months ended September 30, 2021. Gross profit increased in the third quarter of 2022 due to higher sales levels, while margins decreased due to higher steel costs as well as a less favorable product sales mix.

Selling, general and administrative expenses stayed relatively flat at $2.2 million, or 5.2% of sales, in the three months ended September 30, 2022, as compared to $2.2 million, or 5.9% of sales, in the three months ended September 30, 2021.

Operating profit increased $0.1 million to $6.8 million, or 15.6% of sales, in the three months ended September 30, 2022, as compared to $6.7 million, or 17.6% of sales, in the three months ended September 30, 2021, primarily due to increased sales levels which were partially offset by higher steel costs as well as a less favorable product sales mix.

Corporate. Corporate expenses consist of the following (dollars in millions):

Three months ended September 30, 2022 2021
Corporate operating expenses $5.5 $5.5
Non-cash stock compensation 2.4 1.6
Legacy expenses 0.2 0.1
Corporate expenses $8.1 $7.2

Corporate expenses increased $0.9 million to $8.1 million for the three months ended September 30, 2022, from $7.2 million for the three months ended September 30, 2021, primarily as a result of an increase in non-cash stock compensation due to timing differences in expense recognition as well as higher estimated attainment of awards in three months ended September 30, 2022 compared to the three months ended September 30, 2021.

Nine Months Ended September 30, 2022 Compared with Nine Months Ended September 30, 2021

Overall, net sales increased $32.4 million, or 5.0%, to $680.5 million for the nine months ended September 30, 2022, as compared with $648.1 million in the nine months ended September 30, 2021, primarily as a result of our Intertech, Omega and TFI acquisitions, which collectively added $37.6 million of sales. Organic sales, excluding the impact of currency exchange and acquisitions, increased $8.1 million, as increases of industrial products in our Specialty Products segment as well as for food and beverage and industrial products in our Packaging segment were partially offset by declines in dispensing products that help fight the spread of germs in our Packaging segment, as demand for these products abated from peak levels following the pandemic, as well as the expected loss of sales of customers' stocking orders for highly-engineered fasteners in our Aerospace segment. In addition, net sales decreased by $13.4 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of a strengthening U.S. dollar relative to foreign currencies.

Gross profit margin (gross profit as a percentage of sales) approximated 23.9% and 25.9% for the nine months ended September 30, 2022 and 2021, respectively. Gross profit margin decreased primarily due to a less favorable sales mix, primarily as a result of lower sales of Aerospace segment customers' stocking orders for highly-engineered fasteners, as well as due to production inefficiencies resulting from supply chain constraints and volatility in labor availability during the nine months ended September 30, 2022. In addition, higher sales and improved recovery of resin costs in our Packaging segment was offset by higher energy costs, primarily in our European Packaging segment facilities, higher steel costs in our Specialty Products segment, and unfavorable currency exchange.

Operating profit margin (operating profit as a percentage of sales) approximated 10.7% and 12.0% for the nine months ended September 30, 2022 and 2021, respectively. Operating profit decreased $4.7 million, to $72.8 million, for the nine months ended September 30, 2022, compared to $77.5 million for the nine months ended September 30, 2021, primarily due to a less favorable product sales mix, production inefficiencies resulting from supply chain constraints and volatility in labor availability and unfavorable currency exchange, partially offset by improved recovery of resin costs, $4.4 million of lower realignment costs and a pre-tax gain of $4.8 million within our Aerospace segment for the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility.

Interest expense decreased $0.6 million, to $10.5 million, for the nine months ended September 30, 2022, as compared to $11.1 million for the nine months ended September 30, 2021, due to a lower effective interest rate and a decrease in our weighted average borrowings.

In the nine months ended September 30, 2021, we incurred $10.5 million of debt financing and related expenses, of which $10.3 million related to expenses associated with the redemption of our 2025 Senior Notes and $0.2 million related to the write-off of previously capitalized deferred financing fees associated with our Credit Agreement.

Other income (expense) increased $1.7 million to $0.9 million of income for the nine months ended September 30, 2022, as compared to $0.8 million of expense for the nine months ended September 30, 2021, primarily due to an increase in foreign currency transaction gains.

The effective income tax rate for the nine months ended September 30, 2022 and 2021 was 25.0% and 19.2%, respectively. We recorded tax expense of $15.8 million for the nine months ended September 30, 2022 as compared to $10.6 million for the nine months ended September 30, 2021. The rate for the nine months ended September 30, 2022 is higher than in the prior year as the effective tax rate for the nine months ended September 30, 2021 was impacted by the recognition of $3.0 million of deferred tax benefits in Italy, the majority of which related to a reduction in deferred tax liabilities in connection with certain tax incentives.

Net income increased by $2.8 million, to $47.3 million for the nine months ended September 30, 2022, compared to $44.5 million for the nine months ended September 30, 2021. The increase was primarily the result of a decrease in debt financing and related expenses of $10.5 million, an increase in other income of $1.7 million and a decrease in interest expense of $0.6 million, partially offset by a decrease in operating profit of $4.7 million and an increase in income tax expense of $5.2 million.

See below for a discussion of operating results by segment.

Packaging. Net sales increased $6.8 million, or 1.7%, to $416.5 million in the nine months ended September 30, 2022, as compared to $409.7 million in the nine months ended September 30, 2021. Our recent Intertech and Omega acquisitions collectively contributed $33.5 million of sales during the nine months ended September 30, 2022. Sales of products used in food and beverage markets increased by $21.1 million, primarily due to strong demand for closures, dispensers and flexible packaging as the hospitality sector continues to rebound from prior COVID-19 pandemic-related shutdowns. Sales of products used in industrial markets increased by $4.8 million, primarily as a result of higher demand for closure products in North America. Sales of dispensing products used in beauty and personal care, as well as home care, applications that help fight the spread of germs decreased by $37.6 million, as COVID-19-related demand levels have abated for these products from the peak levels, as well as more recently due to further lower demand from large consumer goods customers who have communicated they are rebalancing on-hand inventory levels given the current macro-economic environment. Net sales decreased by $13.2 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening U.S. dollar relative to foreign currencies, as compared to the nine months ended 2021.

Packaging's gross profit decreased $4.4 million to $109.4 million, or 26.3% of sales, in the nine months ended September 30, 2022, as compared to $113.8 million, or 27.8% of sales, in the nine months ended September 30, 2021. During the first nine months of 2021, we were impacted by $9 million of higher resin costs than we were able to recover via commercial actions. We have generally been able to recover such costs during the first nine months of 2022, as market prices have generally stabilized. The increase in gross profit from higher sales levels and improved material cost recovery was more than offset by $5.2 million of higher energy costs, primarily in our European manufacturing facilities, as well as $3.4 million of currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening U.S. dollar relative to foreign currencies. In addition, gross profit margin declined as a result of a less favorable product sales mix.

Packaging's selling, general and administrative expenses increased $5.3 million to $42.4 million, or 10.2% of sales, in the nine months ended September 30, 2022, as compared to $37.1 million, or 9.1% of sales, in the nine months ended September 30, 2021, primarily due to higher ongoing selling, general and administrative costs associated with our acquisitions as we integrate them into our portfolio, as well as higher employee-related expenses as a result of our realignment actions, partially offset by lower intangible asset amortization expense due to certain assets becoming fully amortized.

Packaging's operating profit decreased $9.8 million to $66.7 million, or 16.0% of sales, in the nine months ended September 30, 2022, as compared to $76.5 million, or 18.7% of sales, in the nine months ended September 30, 2021, as the impact of higher sales levels and improved recovery of material costs was offset by a less favorable product sales mix, higher energy costs, higher selling, general and administrative expenses and the impact of $1.7 million of unfavorable currency exchange.

Aerospace. Net sales for the nine months ended September 30, 2022 increased $1.7 million, or 1.2%, to $137.3 million, as compared to $135.7 million in the nine months ended September 30, 2021. Our December 2021 acquisition of TFI contributed $4.1 million in sales. Sales of our fasteners products decreased by $1.8 million, as increases in demand for fasteners used in new aircraft builds plus market share gains was more than offset by the expected loss of sales of customers' stocking orders for highly-engineered fasteners that were predominantly fulfilled throughout 2021. Sales of our engineered components products decreased by $0.6 million, primarily due to lower end market demand.

Gross profit within Aerospace decreased $4.7 million to $25.8 million, or 18.8% of sales, in the nine months ended September 30, 2022, from $30.4 million, or 22.4% of sales, in the nine months ended September 30, 2021, primarily due to a less favorable product sales mix in the first nine months of 2022, with lower sales of the customers' stocking orders for highly-engineered fasteners, as well as production inefficiencies resulting from supply chain constraints and volatility in labor availability.

Selling, general and administrative expenses increased $1.4 million to $21.3 million, or 15.5% of sales, in the nine months ended September 30, 2022, as compared to $19.8 million, or 14.6% of sales, in the nine months ended September 30, 2021, primarily due to higher ongoing selling, general and administrative costs associated with our acquisition of TFI and higher employee-related costs, partially offset by lower third-party expenses.

Operating profit within Aerospace decreased $1.3 million to $9.3 million, or 6.8% of sales, in the nine months ended September 30, 2022, as compared to $10.6 million, or 7.8% of sales, in the nine months ended September 30, 2021, as the impact of a $4.8 million pre-tax gain on the sale of vacant land adjacent to our Tolleson, Arizona manufacturing facility in third quarter 2022 and higher sales levels was more than offset by a less favorable product sales mix, production inefficiencies resulting from supply chain constraints and volatility in labor availability and higher selling, general and administrative expenses.

Specialty Products. Net sales for the nine months ended September 30, 2022 increased $23.9 million, or 23.3%, to $126.7 million, as compared to $102.7 million in the nine months ended September 30, 2021. Sales of our cylinder products increased $15.1 million, due to higher demand for steel cylinders in North America as industrial activity continues to increase from depressed levels as a result of the COVID-19 pandemic. Sales of engines, compressors and related parts used in stationary power generation and assistance applications for natural gas and crude oil extraction increased by $8.8 million, primarily as a result of higher oil-field activity in North America.

Gross profit within Specialty Products increased $4.0 million to $27.6 million, or 21.8% of sales, in the nine months ended September 30, 2022, as compared to $23.6 million, or 23.0% of sales, in the nine months ended September 30, 2021. Gross profit increased due to higher sales levels, while margins decreased due to higher steel costs.

Selling, general and administrative expenses within Specialty Products increased $0.3 million to $6.8 million, or 5.4% of sales, in the nine months ended September 30, 2022, as compared to $6.5 million, or 6.3% of sales, in the nine months ended September 30, 2021, primarily due to higher employment and spending levels in support of the increase in sales levels.

Operating profit within Specialty Products increased $3.6 million to $20.8 million, or 16.4% of sales, in the nine months ended September 30, 2022, as compared to $17.2 million, or 16.7% of sales, in the nine months ended September 30, 2021, primarily due to increased sales levels.

Corporate. Corporate expenses, net consist of the following (dollars in millions):

Nine months ended September 30, 2022 2021
Corporate operating expenses $15.9 $18.5
Non-cash stock compensation 7.7 7.3
Legacy expenses 0.4 1.0
Corporate expenses $24.0 $26.8

Corporate expenses decreased $2.8 million to $24.0 million for the nine months ended September 30, 2022, from $26.8 million for the nine months ended September 30, 2021, primarily as a result of the realignment charges related to the corporate office legal and finance groups in the nine months ended September 30, 2021.

Liquidity and Capital Resources

Cash Flows

Cash flows provided by operating activities were $46.6 million for the nine months ended September 30, 2022, as compared to $77.7 million for the nine months ended September 30, 2021. Significant changes in cash flows provided by operating activities and the reasons for such changes were as follows:

  • For the nine months ended September 30, 2022, the Company generated $88.5 million in cash flows, based on the reported net income of $47.3 million and after considering the effects of non-cash items related to depreciation, amortization, (gain) loss on dispositions of assets, changes in deferred income taxes, stock-based compensation and other operating activities. For the nine months ended September 30, 2021, the Company generated $110.2 million in cash flows based on the reported net income of $44.5 million and after considering the effects of similar non-cash items and debt financing and related expenses.
  • Increases in accounts receivable resulted in a use of cash of $14.8 million and $23.3 million for the nine months ended September 30, 2022 and 2021, respectively. The increased use of cash for each of the nine month periods is due primarily to the timing of sales and collection of cash related thereto within the periods. Days sales outstanding of receivables increased by four days through the nine months ended September 30, 2022, and increased by two days through the nine months ended September 30, 2021.
  • We increased our investment in inventory by $19.0 million and $5.9 million for the nine months ended September 30, 2022 and 2021, respectively. The increase in 2022 is primarily a result of proactively investing in certain raw materials and purchased components to protect against supply chain disruptions and potential cost increases.
  • Increases in prepaid expenses and other assets resulted in a use of cash of $1.2 million and $3.8 million for the nine months ended September 30, 2022 and 2021, respectively. These changes were primarily a result of the timing of payments made for income taxes and certain operating expenses.
  • A decrease in accounts payable and accrued liabilities resulted in a use of cash of $6.9 million for the nine months ended September 30, 2022, while an increase in accounts payable and accrued liabilities resulted in a source of cash of $0.5 million for the nine months ended September 30, 2021. Days accounts payable on hand remained consistent through the nine months ended September 30, 2022 and 2021. Our days accounts payable on hand fluctuate primarily as a result of the timing of payments made to suppliers and the mix of vendors and related terms.

Net cash used for investing activities for the nine months ended September 30, 2022 and 2021 was $69.5 million and $29.7 million, respectively. During the first nine months of 2022, we invested $31.8 million in capital expenditures, as we continued our investment in growth, capacity and productivity-related capital projects, paid $64.1 million, net of cash acquired, to acquire Intertech, and received proceeds of $26.2 million from the termination of our cross-currency swap agreements. During the first nine months of 2021, we invested $29.9 million in capital expenditures. While we sold the land adjacent to our Tolleson, Arizona manufacturing facility during third quarter 2022, we did not receive the cash proceeds until October 2022.

Net cash used for financing activities for the nine months ended September 30, 2022 was $37.5 million, while net cash provided by financing activities was $15.0 million for the nine months ended September 30, 2021. During the nine months ended September 30, 2022, we purchased $30.0 million of outstanding common stock, used a net cash amount of $2.4 million related to our stock compensation arrangements and paid dividends of $5.2 million. During the nine months ended September 30, 2021, we issued $400.0 million principal amount of the 2029 Senior Notes, made net repayments of $48.6 million on our revolving credit facilities, and redeemed $300.0 million principal amount of the 2025 Senior Notes. In connection with refinancing our long-term debt, we paid $13.6 million of debt financing fees and redemption premium. We also purchased $18.2 million of outstanding common stock and used a net cash amount of $4.7 million related to our stock compensation arrangements.

Our Debt and Other Commitments

In March 2021, we issued the 2029 Senior Notes in a private placement under Rule 144A of the Securities Act of 1933, as amended. We used the proceeds from the 2029 Senior Notes offering to pay fees and expenses of $5.1 million related to the offering and pay fees and expenses of $1.1 million related to amending our Credit Agreement. In connection with the issuance, we completed the redemption of our 2025 Senior Notes, paying $300.0 million to retire the outstanding principal amount plus $7.3 million as a redemption premium. The remaining cash proceeds from the 2029 Senior Notes were used for general corporate purposes, including repaying all outstanding revolving credit facility borrowings. The $5.1 million of fees and expenses related to the 2029 Senior Notes were capitalized as debt issuance costs, while the $7.3 million redemption premium, as well as $3.0 million of unamortized debt issuance costs associated with the 2025 Senior Notes were recorded as expense within debt financing and related expenses in the accompanying consolidated statement of income.

The 2029 Senior Notes accrue interest at a rate of 4.125% per annum, payable semi-annually in arrears on April 15 and October 15. The payment of principal and interest is jointly and severally guaranteed, on a senior unsecured basis, by certain subsidiaries of the Company. The 2029 Senior Notes are pari passu in right of payment with all existing and future senior indebtedness and effectively subordinated to all existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.

Prior to April 15, 2024, we may redeem up to 40% of the principal amount of the 2029 Senior Notes at a redemption price of 104.125% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of one or more equity offerings provided that each such redemption occurs within 90 days of the date of closing of each such equity offering. In addition, prior to April 15, 2024, we may redeem all or part of the 2029 Senior Notes at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date, plus a "make whole" premium.

For the nine months ended September 30, 2022, our consolidated subsidiaries that do not guarantee the 2029 Senior Notes represented 25% of the total of guarantor and non-guarantor net sales, treating each as a consolidated group and excluding intercompany transactions between guarantor and non-guarantor subsidiaries. In addition, our non-guarantor subsidiaries represented 36% and 12% of the total guarantor and non-guarantor assets and liabilities, respectively, as of September 30, 2022, treating the guarantor and non-guarantor subsidiaries each as a consolidated group.

In March 2021, we amended our Credit Agreement in connection with the issuance of the 2029 Senior Notes to extend the maturity date. We incurred fees and expenses of $1.1 million related to the amendment, all of which were capitalized as debt issuance costs. We also recorded $0.2 million of non-cash expense related to the write-off of previously capitalized deferred financing fees. The Credit Agreement consists of a $300.0 million senior secured revolving credit facility, which permits borrowings denominated in specific foreign currencies, subject to a $125.0 million sub limit, maturing on March 29, 2026.

In November 2021, we amended the Credit Agreement to replace LIBOR with a benchmark interest rate determined based on the currency denomination of borrowings. Effective January 1, 2022, the amendment replaced the reference rate terms for U.S. dollar LIBOR borrowings to the Secured Overnight Financing Rate ("SOFR"), British pound sterling LIBOR borrowings to the Sterling Overnight Index Average ("SONIA") and Euro LIBOR borrowings to the Euro Short Term Rate ("ESTR"), all plus a spread of 1.50%. The interest rate spread is based upon the leverage ratio, as defined, as of the most recent determination date.

The Credit Agreement provides for incremental revolving credit commitments in an amount not to exceed the greater of $200.0 million and an amount such that, after giving effect to such incremental commitments and the incurrence of any other indebtedness substantially simultaneously with the making of such commitments, the senior secured net leverage ratio, as defined in the Credit Agreement, is no greater than 3.00 to 1.00. The terms and conditions of any incremental revolving credit facility commitments must be no more favorable than the existing credit facility.

Amounts drawn under our revolving credit facility fluctuate daily based upon our working capital and other ordinary course needs. Availability under our revolving credit facility depends upon, among other things, compliance with our Credit Agreement's financial covenants. Our Credit Agreement contains various negative and affirmative covenants and other requirements affecting us and our subsidiaries, including the ability to, subject to certain exceptions and limitations, incur debt, liens, mergers, investments, loans, advances, guarantee obligations, acquisitions, asset dispositions, sale-leaseback transactions, hedging agreements, dividends and other restricted payments, transactions with affiliates, restrictive agreements and amendments to charters, bylaws, and other material documents. The terms of our Credit Agreement require us and our subsidiaries to meet certain restrictive financial covenants and ratios computed quarterly, including a maximum total net leverage ratio (total consolidated indebtedness plus outstanding amounts under the accounts receivable securitization facility, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined) and a minimum interest expense coverage ratio (consolidated EBITDA, as defined, over the sum of consolidated cash interest expense, as defined, and preferred dividends, as defined). Our permitted total net leverage ratio under the Credit Agreement is 4.00 to 1.00 as of September 30, 2022. If we were to complete an acquisition which qualifies for a Covenant Holiday Period, as defined in our Credit Agreement, then our permitted total net leverage ratio cannot exceed 4.50 to 1.00 during that period. Our actual total net leverage ratio was 2.00 to 1.00 at September 30, 2022. Our permitted interest expense coverage ratio under the Credit Agreement is 3.00 to 1.00 as of September 30, 2022. Our actual interest expense coverage ratio was 13.07 to 1.00 at September 30, 2022. At September 30, 2022, we were in compliance with our financial covenants.

The following is a reconciliation of net income, as reported, which is a GAAP measure of our operating results, to Consolidated Bank EBITDA, as defined in our Credit Agreement, for the twelve months ended September 30, 2022 (dollars in thousands). We present Consolidated Bank EBITDA to show our performance under our financial covenants.

Twelve Months Ended September 30, 2022
Net income $60,150
Bank stipulated adjustments:
Interest expense 13,910
Income tax expense 17,260
Depreciation and amortization 53,500
Non-cash compensation expense(1) 9,860
Other non-cash expenses or losses 660
Non-recurring expenses or costs(2) 11,290
Extraordinary, non-recurring or unusual gains or losses 1,450
Effects of purchase accounting adjustments 1,160
Business and asset dispositions (4,540)
Net losses on early extinguishment of debt —
Permitted acquisitions 2,800
Currency gains and losses (960)
Consolidated Bank EBITDA, as defined $166,540
September 30, 2022
Total Indebtedness, as defined(3) $333,130
Consolidated Bank EBITDA, as defined 166,540
Total net leverage ratio 2.00 x
Covenant requirement 4.00 x

37

Twelve Months Ended September 30, 2022
Interest expense $13,910
Bank stipulated adjustments:
Interest income (270)
Non-cash amounts attributable to amortization of financing costs (900)
Total Consolidated Cash Interest Expense, as defined $12,740
September 30, 2022
Consolidated Bank EBITDA, as defined $166,540
Total Consolidated Cash Interest Expense, as defined 12,740
Actual interest expense coverage ratio 13.07 x
Covenant requirement 3.00 x

(1) Non-cash compensation expenses resulting from the grant of equity awards.

(2) Non-recurring costs and expenses relating to diligence and transaction costs, purchase accounting costs, severance, relocation, restructuring and curtailment expenses.

(3) Includes $3.5 million of acquisition related contingent consideration as of September 30, 2022.

Our revolving credit facility allows for the issuance of letters of credit, not to exceed $40.0 million in aggregate. As of December 31, 2021, we placed restricted cash on deposit with a financial institution to be held as cash collateral for our outstanding letters of credit; therefore, as of December 31, 2021, we had no letters of credit issued against our revolving credit facility. At September 30, 2022, we had no amounts outstanding under our revolving credit facility and had $293.9 million potentially available after giving effect to $6.1 million of letters of credit issued and outstanding. At December 31, 2021, we had no amounts outstanding under our revolving credit facility and had $300.0 million potentially available. Our letters of credit, or corresponding restricted cash deposits, are used for a variety of purposes, including support of certain operating lease agreements, vendor payment terms and other subsidiary operating activities, and to meet various states' requirements to self-insure workers' compensation claims, including incurred but not reported claims. Our borrowing capacity was not reduced by leverage restrictions contained in the Credit Agreement as of September 30, 2022 and December 31, 2021.

We rely upon our cash flow from operations and available liquidity under our revolving credit facility to fund our debt service obligations and other contractual commitments, working capital and capital expenditure requirements. At the end of each quarter, we have historically used cash on hand from our domestic and foreign subsidiaries to pay down amounts outstanding under our revolving credit facility, as applicable.

Our weighted average borrowings during the first nine months of 2022 approximated $400.1 million, compared to $402.5 million during the first nine months of 2021, primarily due to a higher aggregate principal balance on our senior notes due to the issuance of the 2029 Senior Notes and the redemption of the 2025 Senior Notes during the first half of 2021.

In May 2021, we, through one of our non-U.S. subsidiaries, entered into a revolving loan facility with a borrowing capacity of $4 million. The facility is guaranteed by TriMas Corporation. There were no borrowings on this loan facility as of September 30, 2022.

Cash management related to our revolving credit facility is centralized. We monitor our cash position and available liquidity on a daily basis and forecast our cash needs on a weekly basis within the current quarter and on a monthly basis outside the current quarter over the remainder of the year. Our business and related cash forecasts are updated monthly.

More than half of our cash on hand as of September 30, 2022 is located within the U.S., and given available funding under our revolving credit facility of $300.0 million at September 30, 2022 (after consideration of the aforementioned leverage restrictions) and based on forecasted cash sources and requirements inherent in our business plans, we believe that our liquidity and capital resources, including anticipated cash flows from operations, will be sufficient to meet our debt service, capital expenditure and other short-term and long-term obligations for the foreseeable future, as well as dividends and share repurchases.

We are subject to variable interest rates on our revolving credit facility, which is subject to a benchmark interest rate determined based on the currency denomination of borrowings. At September 30, 2022, we had no amounts outstanding on our revolving credit facility and, therefore, no variable rate-based borrowings outstanding.

In addition to our long-term debt, we have other cash commitments related to leases. We account for these lease transactions as operating leases, and annual rent expense for continuing operations related thereto approximated $11.0 million in 2021. We expect leasing will continue to be an available financing option to fund future capital expenditure requirements.

In March 2020, we announced our Board of Directors had authorized us to increase the purchase of our common stock up to $250 million in the aggregate, an increase of $100 million from the prior authorization. In the three and nine months ended September 30, 2022, we purchased 76,167 and 1,004,154 shares of our outstanding common stock for an aggregate purchase price of $2.1 million and $30.0 million, respectively. Since the initial authorization through September 30, 2022, we have purchased 4,854,969 shares of our outstanding common stock for an aggregate purchase price of $137.3 million. We will continue to evaluate opportunities to return capital to shareholders through the purchase of our common stock and the payment of dividends, depending on market conditions, including the potential impact of the COVID-19 pandemic, and other factors.

Market Risk

We conduct business in various locations throughout the world and are subject to market risk due to changes in the value of foreign currencies. The functional currencies of our foreign subsidiaries are primarily the local currency in the country of domicile. We manage these operating activities at the local level and revenues and costs are generally denominated in local currencies; however, results of operations and assets and liabilities reported in U.S. dollars will fluctuate with changes in exchange rates between such local currencies and the U.S. dollar.

We use derivative financial instruments to manage currency risks associated with our procurement activities denominated in currencies other than the functional currency of our subsidiaries and the impact of currency rate volatility on our earnings. As of September 30, 2022, we were party to foreign exchange forward and swap contracts to hedge changes in foreign currency exchange rates with notional amounts of $130.4 million. We also use cross-currency swap agreements to mitigate currency risks associated with the net investment in certain of our foreign subsidiaries. See Note 11, "Derivative Instruments," included in Part 1, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q for additional information.

We are also subject to interest risk as it relates to our long-term debt. See Note 10, "Long-term Debt," included in Part 1, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q for additional information.

Common Stock

TriMas is listed in the NASDAQ Global Select Market. Our stock trades under the symbol "TRS."

Credit Rating

We and certain of our outstanding debt obligations are rated by Standard & Poor's and Moody's. On March 29, 2022, Moody's affirmed a Ba3 rating to our 2029 Senior Notes. See Note 10, "Long-term Debt" included in Part I, Item 1, "Notes to Unaudited Consolidated Financial Statements" within this quarterly report on Form 10-Q. Moody's also affirmed a Ba2 Corporate Family Rating and maintained its outlook as stable. On May 12, 2022, Standard & Poor's affirmed a BB- rating to our 2029 Senior Notes. Standard & Poor also affirmed a BB corporate credit rating and maintained its outlook as stable. If our credit ratings were to decline, our ability to access certain financial markets may become limited, our cost of borrowings may increase, the perception of us in the view of our customers, suppliers and security holders may worsen and as a result, we may be adversely affected.

Outlook

Looking forward, we believe there will be a continued period of uncertainty related to demand levels for our products, whether it be the timing of when our large consumer goods customers increase their orders for beauty and personal care and home care products given their current inventory levels and end-consumer demand, if production rates for new aircraft builds continue to increase as expected, or whether general industrial activity will continue to its upward trajectory or begin to level-off given the current macro-economic environment. No matter the outcome of these factors, we expect to continue to mitigate, as much as practical, the impact of the most challenged end markets, executing realignment actions as necessary and taking other proactive actions where possible such as monetizing non-core properties so we maintain our strong balance sheet and are positioned to gain operating leverage when these end markets recover. We believe we remain well positioned to capitalize on the recovery of the aerospace market, just as we have with the improvement in the industrial markets, as well as capture available market growth opportunities.

Following our recent acquisitions, we continue to believe our capital structure remains strong and that we have sufficient headroom under our financial covenants, and sufficient cash and available liquidity under our revolving credit facility, to meet our debt service, capital expenditure and other short-term and long-term obligations for at least the next 12 months and for the foreseeable future thereafter, as well as dividends and share repurchases.

We expect to continue to leverage the tenets of our TriMas Business Model to manage our multi-industry businesses on a longer-term basis, achieve our growth plans, execute continuous improvement initiatives to offset inflationary pressures, and seek lower-cost sources for input costs, all while continuously assessing the appropriateness of our manufacturing footprint and fixed-cost structure.

Impact of New Accounting Standards

See Note 2, "New Accounting Pronouncements," included in Part 1, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q.

Critical Accounting Policies

Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions used in calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, our evaluation of business and macroeconomic trends, and information from other outside sources, as appropriate.

During the quarter ended September 30, 2022, there were no material changes to the items that we disclosed as our critical accounting policies in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," in the Annual Report on Form 10-K for the year ended December 31, 2021.

Market risk

As filed, 650 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the normal course of business, we are exposed to market risk associated with fluctuations in foreign currency exchange rates. We are also subject to interest risk as it relates to long-term debt. See Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," for details about our primary market risks, and the objectives and strategies used to manage these risks. Also see Note 10, "Long-term Debt," and Note 11, "Derivative Instruments," in Part I, Item 1, "Notes to Unaudited Consolidated Financial Statements," included within this quarterly report on Form 10-Q for additional information.

Controls and procedures

As filed, 2,097 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Evaluation of disclosure controls and procedures

As of September 30, 2022, an evaluation was carried out by management, with the participation of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) pursuant to Rule 13a-15 of the Exchange Act. The Company's disclosure controls and procedures are designed only to provide reasonable assurance that they will meet their objectives. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that as of September 30, 2022, the Company's disclosure controls and procedures are effective to provide reasonable assurance that they would meet their objectives.

Changes in internal control over financial reporting

In response to the COVID-19 pandemic, we have required certain employees, some of whom are involved in the operation of our internal controls over financial reporting, to work from home. Despite this change, there have been no changes in the Company's internal control over financial reporting during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting. We are continually monitoring and assessing the COVID-19 pandemic on our internal controls to minimize any impact it may have on their design and operating effectiveness.

Risk factors

As filed, 388 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part 1, Item 1A., "Risk Factors," in our 2021 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. There have been no significant changes in our risk factors as disclosed in our 2021 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$218.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$680.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$170.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-01-01 to 2022-09-30$517.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-07-01 to 2022-09-30$48.3mus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-09-30$162.7mus-gaap:GrossProfit
Selling, general and administrative3 months2022-07-01 to 2022-09-30$32.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-09-30$94.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-01 to 2022-09-30$21.0mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30$72.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$3.6mus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$10.5mus-gaap:InterestExpense
Income tax3 months2022-07-01 to 2022-09-30$4.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$15.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30$13.3mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30$47.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30$0.32us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$1.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30$0.32us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$1.12us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-3042,181,440 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-3042,590,777 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30$46.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-09-30$31.8mus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid9 months2022-01-01 to 2022-09-30$5.2mus-gaap:PaymentsOfDividends
Share repurchases9 months2022-01-01 to 2022-09-30$30.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-09-30$80.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$416.8mus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$1.30bnus-gaap:Assets
Current liabilitiesAt period end2022-09-30$158.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-09-30$667.3mus-gaap:Liabilities
Shareholders' equityAt period end2022-09-30$634.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000842633-22-000084. Last ingested by Listed: Nov 15, 2026, 01:26 ET. Listed shows no prices and gives no investment advice.